Asset Publisher

Translation and Impact

Biomedical Innovation and Access to Essential Medicines: Alternatives to a Broken Model

15.03.2016

First report in the series "Innovation and Access". The publication analyses the current research system and sets the stage for a debate involving all the stakeholders with the aim of finding a balance between pharmaceutical innovation, the public interest and access to essential treatments.